ESR1 and triple-negative breast carcinoma: In TCGA, triple-negative breast cancer (TNBC) had the highest rate of HLA LOH (17/61 (28%)), followed by estrogen receptor negative (ER−; 7/32 (22%)) and estrogen receptor positive (ER+; 60/402 (15%); Extended Data Fig. 6).